Susanne Kaestner joins the company as Senior Vice President, Quality and member of the Executive Team, and Dr. Thea Boehm as Vice President, Business Development.
C2i Genomics expands its global reach and brings the first whole-genome sequencing minimal residual disease test to India
A research group led by Ben-Gurion University of the Negev managed to produce an innovative microchip for creating sperm in a culture by using a microfluidic system.
To address the preventive & primary healthcare delivery gaps in India
The partnership between Lockwood and Random42 expands the capabilities and geographic footprint for both organizations.
Facility features LED lighting, solar panels, automation and innovative temperature-controlled systems to maximize efficiency and minimize environmental impact
GSK to pay $2.1 billion upfront and up to $1.2 billion in potential development milestones
Construction will begin in early 2023, and the plant is scheduled to go onstream in 2025
The new Oncology CRO will aim to drive faster execution and higher quality trial outcomes for Oncology sponsors.
120+ members of multi-disciplinary medical team are trained to provide seamless, outcome driven trauma and emergency care
Subscribe To Our Newsletter & Stay Updated
